Exposure to Pyriproxyfen Impacts Heart Development Causing Tissue and Cellular Impairments, Heart Arrhythmia and Reduced Embryonic Growth
Cardiovascular Toxicology · 2025
DOI: 10.1007/s12012-024-09944-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2025. Verfasst von Maria Fernanda Conte Bernhardt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biologia Celular, Embriologia e Genética, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Pyridines, Arrhythmias, Cardiac, Heart, Insecticides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
In recent years, concerns have been raised regarding the safety of exposure to pyriproxyfen (PPF), a larvicide commonly used in drinking water reservoirs to control populations of disease-vector mosquitoes for human safety. These concerns are focused mainly on exposure by pregnant women, since studies have shown deleterious effects of PPF on embryonic development, mainly addressing the central nervous system. However, since previous studies showed reduced growth in embryos exposed to PPF, we hypothesize that PPF exposure impairs the cardiovascular system, responsible for ensuring appropriate blood supply, which leads to stunted growth. This study aimed to investigate the impact of PPF exposure on heart ventricular morphology, its influence on cell proliferation and apoptosis, as well as assess the impact on the functionality of the heart and on embryonic growth. Chicken embryos were used as a model and two sublethal concentrations were tested: 0.01 mg/L and 10 mg/L PPF. Thinning of cardiac tissue was evident in heart structures at 10 mg/L PPF. Furthermore, DNA double-strand breaks and reduced cell proliferation were observed, combined with decreased apoptosis suggesting cell cycle arrest, especially in the left ventricle for both concentrations. In addition, these PPF concentrations induced heart arrhythmia, although no changes in heart rate were observed. Embryos exposed to 0.01 mg/L showed reduced body and heart mass, crown-rump length, and thoracic perimeter, while head circumference was reduced in both exposed groups. Together, combining morphological, molecular, and physiological parameters, this study showed the cardiotoxic effects of PPF exposure and elucidated its impacts on embryonic growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biologia Celular, Embriologia e Genética, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.
- Departamento de Biologia Celular, Embriologia e Genética, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil. evelise.nazari@ufsc.br.
ORCID-Profile: Maria Fernanda Conte Bernhardt, Nathália Ronconi-Krüger, Evelise Maria Nazari
Förderung
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Bernhardt, M. F. C., Ronconi-Krüger, N., & Nazari, E. M. (2025). Exposure to Pyriproxyfen Impacts Heart Development Causing Tissue and Cellular Impairments, Heart Arrhythmia and Reduced Embryonic Growth. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09944-4
Vancouver
Bernhardt MFC, Ronconi-Krüger N, Nazari EM. Exposure to Pyriproxyfen Impacts Heart Development Causing Tissue and Cellular Impairments, Heart Arrhythmia and Reduced Embryonic Growth. Cardiovascular Toxicology. 2025. doi:10.1007/s12012-024-09944-4
BibTeX
@article{Bernhardt2025,
author = {Bernhardt, Maria Fernanda Conte and Ronconi-Krüger, Nathália and Nazari, Evelise Maria},
title = {Exposure to Pyriproxyfen Impacts Heart Development Causing Tissue and Cellular Impairments, Heart Arrhythmia and Reduced Embryonic Growth},
journal = {Cardiovascular Toxicology},
year = {2025},
doi = {10.1007/s12012-024-09944-4}
}
EUVIMED